INNOVANCE Anti-Xa assay
Simplify your anticoagulant testing
Receive your quote directly from the manufacturer.
The INNOVANCE Anti-Xa assay is an automated chromogenic assay for the quantitative determination of the activity of unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) as well as rivaroxaban,* apixaban and edoxaban* concentrations in citrated human plasma. The INNOVANCE Anti-Xa assay combines a truly ready-to-use liquid reagent for heparin and DOAC testing, allowing 24/7 access to rapid, specific testing for anticoagulants. Unlike most commercially available solutions, this assay requires no manual preparation or waiting time. INNOVANCE Anti-Xa assay has now been extended to test for edoxaban.*
*Not available for sale in the U.S. Product availability may vary from country to country and is subject to varying regulatory requirements.
All trademarks are the property of their respective owners.
Antithrombin blood test from Siemens Healthineers now FDA cleared as a companion diagnostic for Qfitlia, a Sanofi hemophilia therapy
Measuring antithrombin activity levels helps people receive the appropriate dose, initially and over time
Innovative anti-Xa assay sets new standard in anticoagulant diagnostics
The INNOVANCE Anti-Xa assay for anticoagulant therapy management delivers fully automated, ready-to-use testing for heparins, rivaroxaban, apixaban, and edoxaban
